These innovative treatments, Retatrutide, represent a remarkable advancement in managing metabolic dysfunction and possibly related ailments . These drugs are categorized as GLP-1 receptor agonists , indicating these substances to emulate the endogenous GLP-1 peptide, enhancing insulin secretion and reducing appetite . While Tirzepatide each operat